Ovarian cancer

Kathleen R. Cho, Ie Ming Shih

Research output: Contribution to journalReview articlepeer-review

Abstract

Ovarian carcinomas are a heterogeneous group of neoplasms and are traditionally subclassified based on type and degree of differentiation. Although current clinical management of ovarian carcinoma largely fails to take this heterogeneity into account, it is becoming evident that each major histological type has characteristic genetic defects that deregulate specific signaling pathways in the tumor cells. Moreover, within the most common histological types, the molecular pathogenesis of low-grade versus high-grade tumors appears to be largely distinct. Mouse models of ovarian carcinoma have been developed that recapitulate many of the morphological features, biological behavior, and gene-expression patterns of selected subtypes of ovarian cancer. Such models will likely prove useful for studying ovarian cancer biology and for preclinical testing of molecularly targeted therapeutics, which may ultimately lead to better clinical outcomes for women with ovarian cancer.

Original languageEnglish (US)
Pages (from-to)287-313
Number of pages27
JournalAnnual Review of Pathology: Mechanisms of Disease
Volume4
DOIs
StatePublished - Feb 2009

Keywords

  • Classification
  • Endometrioid
  • Genetics
  • Mouse models
  • Serous

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Ovarian cancer'. Together they form a unique fingerprint.

Cite this